• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION PALMAZ GENESIS ON AMIIA; ENDOVASCULAR SDS/STENTS (FGE)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION PALMAZ GENESIS ON AMIIA; ENDOVASCULAR SDS/STENTS (FGE) Back to Search Results
Catalog Number PG1560PMW
Device Problems Material Frayed (1262); Torn Material (3024)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/02/2015
Event Type  malfunction  
Event Description
As reported, during a percutaneous transluminal angioplasty (pta) after pre-dilation and a guidewire exchange, the physician advanced/approached the intended target lesion twice with a 142 cm.Sds rx palmaz genesis mounted on an amiia 6.0 x 15 stent delivery system (sds).The sds was removed from the patient and the distal tip was noted to be frayed.Another stent was used to complete the procedure successfully.There was no reported patient injury.The product was clinically used and it will be returned for analysis.The target lesion was the right common femoral artery to superficial femoral artery.The lesion was reported to be: a 99% stenosis, heavily calcified and mildly tortuous.Additional information has been requested.
 
Manufacturer Narrative
Concomitant products: cruise, st.Jude medical guidewire; chevalier universal,fmd guidewire.The product was returned for evaluation and testing; however, the engineering evaluation is not complete.Additional information will be submitted within 30 days upon receipt.
 
Manufacturer Narrative
During a percutaneous transluminal angioplasty (pta) after pre-dilation and a guidewire exchange, the physician advanced/approached the intended target lesion twice with a 142 cm.Sds rx palmaz genesis mounted on an amiia 6.0 x 15 stent delivery system (sds).The sds was removed from the patient and the distal tip was noted to be frayed.Another stent was used to complete the procedure successfully.There was no reported patient injury.The target lesion was the right common femoral artery to superficial femoral artery.The lesion was reported to be a 99% stenosis, heavily calcified and mildly tortuous.Multiple attempts to obtain additional information were unsuccessful.The product was returned for analysis.A non-sterile unit of sds rx genesis amiia 6.0x15 142cm was returned.Per visual analysis the stent was in the correct position.No damages were observed.Per functional analysis a 0.014¿ guide wire (lab sample) was inserted to the tip of the wire lumen.When the wire was advanced through the wire lumen dried blood residues came out from the transition seal.The internal diameter of guide wire lumen was measured using a lab sample 0.014¿ and it was found to be within specification.The outer diameter of the proximal balloon seal was measured and it was found within specification.Per microscopic analysis the distal tip was observed to be frayed and split; no damages were observed on the marker bands, stent and balloon.The lot number was not provided; therefore a device history record (dhr) review could not be performed.The event reported by the customer as ¿stent delivery system (sds)- tracking difficulty¿ was not confirmed as functional and dimensional analysis was performed successfully.The event reported by the customer as ¿distal tip/ frayed/split/torn-in patient (peripheral)¿ was confirmed through analysis of the returned device as the distal tip was observed to be frayed and split.The exact cause of the event could not be determined during analysis.Based on the information available for review, vessel characteristics (heavy calcification, mild tortuosity and a rate of stenosis of 99%) may have contributed to the burst as evidenced by abrasions noted on the outer surface during analysis.Neither the dhr review nor the product analysis suggests that the event experienced by the customer could be related to the manufacturing process; therefore, no corrective/preventive action will be taken.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PALMAZ GENESIS ON AMIIA
Type of Device
ENDOVASCULAR SDS/STENTS (FGE)
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60th avenue
miami lakes FL
Manufacturer Contact
cecil navajas
circuito interior norte #1820
juarez chihuahua 32580
MX   32580
7863133880
MDR Report Key4936252
MDR Text Key6039697
Report Number9616099-2015-00314
Device Sequence Number1
Product Code FGE
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative,company represent
Reporter Occupation Health Professional
Type of Report Initial
Report Date 08/14/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberPG1560PMW
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/07/2015
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/02/2015
Initial Date FDA Received07/23/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-